Introduction
============

A longstanding debate in evolutionary biology concerns how species of increasing structural complexity maintain their capacity for genetic variation---and, hence, adaptation and divergence---despite a predictably increasing need for genetic fidelity ([@bib52]; [@bib51]). Relevant to this conflict, Cope\'s rule postulates that increasing body size creates a short-term reproductive advantage for the individual organism ([@bib74]) while worsening long-term extinction risk for the clade ([@bib140]; [@bib60]). This trade-off suggests that higher evolving organisms are subject to a progressive "Red Queen"--type clash between intensifying negative selection for phenotypic stability and weakening positive selection for genotypic variability ([@bib90])---consistent with the modest proportion (0.03%) of coding sequence estimated to have been positively selected in humans, when compared with that negatively selected (2.5--5%) in humans or positively selected in simpler species such as *Drosophila* (20%) ([@bib118]). Indeed, prevailing theory teaches that most genetic novelty results from fixation of random (nonadaptive) drift affecting neutral ([@bib72]) or near-neutral ([@bib109]) alleles, rejecting the Lamarckian doctrine that environmental pressures can drive (i.e., not merely fix) beneficial mutations.

In previous work, we showed that silent mutations may nonrandomly affect intragenic sites of differing functional importance ([@bib33]; [@bib83]) and that such mutational patterns vary with both strand-specific transcription-related DNA repair ([@bib135]) and gene expression levels ([@bib134]). It therefore remains plausible that ambient stressors such as heat ([@bib89]), starvation ([@bib56]), inflammation ([@bib10]; [@bib79]), toxins ([@bib121]), free radical injury ([@bib16]), or other sources of DNA damage ([@bib117]) could modify gene transcription and thus alter the rate of mutations affecting fitness ([@bib48])---including the occasional generation of beneficial mutations ([@bib95]; [@bib31]; [@bib100]). Clues favoring this inducible (adaptive) evolutionary paradigm over neutrality for metazoan genomes---as is already accepted for bacterial ([@bib117]; [@bib18]) and plant genomes ([@bib49])---include faster-than-expected rates of phenotype acquisition, close temporal correlation with environmental changes, proof of improved fitness, or convergence ([@bib81]).

A mechanism for such non-Darwinian genomic plasticity has been suggested in recent times by the discovery of heritable epigenetic changes capable of reprogramming developmental and adult gene expression ([@bib91]; [@bib97]), coupled with the predisposition of such changes to cause germ line mutations ([@bib23]) or postzygotic mosaicism ([@bib108]) that sometimes cause disease ([@bib3]; [@bib128]; [@bib36]). The frequency of germ line epimutations or imprinting errors---estimated to be an order of magnitude higher than that of germ line mutations ([@bib61])---can be either environmentally regulated ([@bib28]), as illustrated by the inducibility of spermatogonial stem cell DNA hypermethylation by air pollution ([@bib148]), or parentally age dependent ([@bib107]; [@bib113]). If such epimutations affect modifier genes involved in DNA repair, a "slippery slope" of somatic and transgenerational genetic instability (i.e., a mutator phenotype) may result ([@bib67]), leading not only to an increase in deleterious (purifiable) mutations ([@bib145]; [@bib96]) but also to occasional advantageous (positively selectable) mutations ([@bib130]; [@bib18]) and/or speciation events ([@bib129]). Selection of such "driver" beneficial mutations may lead in turn to "hitchhiking" of mutator (epi)mutations in modifier genes ([@bib68]) as "passengers" ([@bib44]). Such mutational buffering could enhance evolvability ([@bib142])---consistent with the idea that error-free DNA repair may be maladaptive in mutagenic or stressful environments ([@bib12]; [@bib117]; [@bib125])---yet may also impair performance and hence robustness ([@bib80]; [@bib42]; [@bib114]). The "evo-devo" conundrum thus remains as to whether evolvability is indeed selectable ([@bib57]; [@bib84]), and if so, by what mechanism ([@bib21]; [@bib115]). Even if such a mechanism exists ([@bib73]; [@bib95]), traditional thinking predicts that such selection may act only very weakly at a "good-for-the-species" level ([@bib59]).

We have addressed this dilemma by comparing 2 classes of human genes implicated in prevention of cancer, a disease of disordered microevolution ([@bib50]; [@bib66]; [@bib11]). Tumorigenesis is potentiated by genomic instability ([@bib124]; [@bib9]) arising via multistep inactivation of so-called tumor suppressor genes ([@bib104]), which, like proto-oncogenes, have been reported to be under strong negative selection pressure ([@bib136]). These carcinogenic loss-of-function events mainly affect DNA repair---mediated by caretaker genes (CTs) such as *BRCA1* and *MLH1*---or apoptosis, mediated by gatekeeper genes (GKs) such as *TP53* and *Rb* ([@bib75]). These suppressor gene subsets, as well as their disease-causing mutations ([@bib45]; [@bib139]), are distinguishable using gene databases ([@bib27]; [@bib144]). Although long regarded as recessive oncogenes that require 2 "hits" for disease expression ([@bib77]), suppressor genes are increasingly recognized to exhibit clonal haploinsufficiency in tumors ([@bib122]; [@bib126]). Given recent evidence for the role of adaptive evolution in cancer progression ([@bib6]; [@bib25]), the occurrence of such haploinsufficiency supports the view that gene loss and pseudogenization ("less is more") can accelerate genome evolution in certain contexts ([@bib110]). Because deleterious mutations (those causing genetic death) are purged by negative selection, whereas nondeleterious mutations may be positively selected, systematic comparison of CT and GK evolutionary rates should clarify whether these repair and apoptosis gene subsets are subject to distinct evolutionary forces. Consistent with this possibility, comparisons of human and chimpanzee genomes have confirmed different evolutionary rates in functionally distinct gene categories related to tumorigenesis ([@bib19]; [@bib13]; [@bib102]; [@bib70]; [@bib141]), whereas adaptive evolution of the *BRCA1* CT has been well documented ([@bib65]; [@bib41]; [@bib112]). Here, we use genomic data mining to test the hypothesis that germ line CTs are commoner targets for methylation-dependent mutational inactivation than are GKs and, hence, that repair gene dysfunction contributes both to germ line evolvability and somatic tumor progression. A male-dependent prezygotic mechanism for this process, which we have termed programmed genetic instability or PGI ([@bib34]), is also presented.

Materials and Methods
=====================

Identification and Classification of CTs and GKs
------------------------------------------------

We mined data to compare the structural and functional characteristics of human CTs and GKs (see [supplement 1](http://mbe.oxfordjournals.org/cgi/content/full/msn126/DC1) \[[Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/msn126/DC1) online\] for sources). Given the multigenic interdependence of DNA repair and cellular apoptosis ([@bib143]), unambiguous identification of genes that exclusively mediate 1 of these 2 processes is not straightforward. We sought to minimize the "noise" of this functional overlap in 2 ways. First, we used a familial tumor suppressor gene database ([@bib45]; [@bib139]) to restrict the choice of genes to those with major neoplastic effects (i.e., heritable cancer syndromes) when deleted in the germ line; this yielded a total of 74 tumor suppressor genes ([table 1](#tbl1){ref-type="table"}). Second, by cross-correlating the former data set with a database of DNA repair genes ([@bib144]), we subclassified this familial cancer susceptibility gene subset as CTs (*n* = 38) and then designated the remainder---the majority of which were confirmed to mediate apoptosis ([@bib27])---as GKs (*n* = 36; [table 1](#tbl1){ref-type="table"}).

###### 

Classification of CT and GK Suppressor Genes, Listing RefSeq, EntrezGene, and Ensembl Identifiers

       CTs        RefSeq         Entrez Gene   Ensembl           GKs         RefSeq         Entrez Gene   Ensembl
  ---- ---------- -------------- ------------- ----------------- ----------- -------------- ------------- -----------------
  1    *ATM*      NM_000051      472           ENST00000278616   *APC*       NM_000038      324           ENST00000257430
  2    *BLM*      NM_000057      641           ENST00000355112   *AXIN2*     NM_004655      8313          ENST00000307078
  3    *BRCA1*    NM_007295      672           ENST00000309486   *BMPR1A*    NM_004329      657           ENST00000372037
  4    *BRCA2*    NM_000059      675           ENST00000267071   *BUB1B*     NM_001211      701           ENST00000287598
  5    *BRIP1*    NM_032043      83990         ENST00000259008   *CDC73*     NM_024529      79577         ENST00000367436
  6    *DDB2*     NM_000107      1643          ENST00000256996   *CDH1*      NM_004360      999           ENST00000268794
  7    *ERCC2*    NM_000400      2068          ENST00000221481   *EXT1*      NM_000127      2131          ENST00000378204
  8    *ERCC3*    NM_000122      2071          ENST00000285398   *MEN1*      NM_130803      4221          ENST00000337652
  9    *ERCC4*    NM_005236      2072          ENST00000311895   *NF1*       NM_000267      4763          ENST00000358273
  10   *ERCC5*    NM_000123      2073          ENST00000375971   *NF2*       NM_000268      4771          ENST00000338641
  11   *ERCC6*    NM_000124      2074          ENST00000355832   *PRKAR1A*   NM_212472      5573          ENST00000358598
  12   *ERCC8*    NM_000082      1161          ENST00000265038   *PTCH*      NM_000264      5727          ENST00000331920
  13   *FANCA*    NM_000135      2175          ENST00000305699   *PTEN*      NM_000314      5728          ENST00000371953
  14   *FANCB*    NM_001018113   2187          ENST00000340604   *RB1*       NM_000321      5925          ENST00000267163
  15   *FANCC*    NM_000136      2176          ENST00000289081   *SBDS*      NM_016038      51119         ENST00000246868
  16   *FANCD2*   NM_033084      2177          ENST00000287647   *SDHB*      NM_003000      6390          ENST00000375499
  17   *FANCE*    NM_021922      2178          ENST00000229769   *SDHC*      NM_003001      6391          ENST00000367975
  18   *FANCF*    NM_022725      2188          ENST00000327470   *SDHD*      NM_003002      6392          ENST00000375549
  19   *FANCG*    NM_004629      2189          ENST00000378643   *SMAD4*     NM_005359      4089          ENST00000342988
  20   *FANCL*    NM_018062      55120         ENST00000233741   *SMARCB1*   NM_001007468   6598          ENST00000344921
  21   *FANCM*    NM_020937      57697         ENST00000267430   *STK11*     NM_000455      6794          ENST00000326873
  22   *LIG4*     NM_002312      3981          ENST00000310534   *SUFU*      NM_016169      51684         ENST00000369902
  23   *MLH1*     NM_000249      4292          ENST00000231790   *TCF1*      NM_000545      6927          ENST00000257555
  24   *MLH3*     NM_014381      27030         ENST00000238662   *TSC1*      NM_000368      7248          ENST00000298552
  25   *MRE11A*   NM_005591      4361          ENST00000323929   *TSC2*      NM_000548      7249          ENST00000219476
  26   *MSH2*     NM_000251      4436          ENST00000233146   *TSHR*      NM_000369      7253          ENST00000298171
  27   *MSH3*     NM_002439      4437          ENST00000265081   *VHL*       NM_000551      7428          ENST00000256474
  28   *MSH6*     NM_000179      2956          ENST00000234420   *WT1*       NM_024426      7490          ENST00000379079
  29   *MUTYH*    NM_012222      4595          ENST00000372112   *CDK4*      NM_000075      1019          ENST00000257904
  30   *NBN*      NM_001024688   4683          ENST00000265433   *CHEK2*     NM_001005735   11200         ENST00000382580
  31   *PMS1*     NM_000534      5378          ENST00000342075   *CYLD*      NM_015247      1540          ENST00000311559
  32   *PMS2*     NM_000535      5395          ENST00000265849   *EXT2*      NM_000401      2132          ENST00000358681
  33   *POLH*     NM_006502      5429          ENST00000372236   *FH*        NM_000143      2271          ENST00000205832
  34   *RAD51*    NM_002875      5888          ENST00000382643   *FLCN*      NM_144997      201163        ENST00000285071
  35   *RECQL4*   NM_002907      5965          ENST00000314748   *GPC3*      NM_004484      2719          ENST00000370818
  36   *WRN*      NM_000553      7486          ENST00000298139   *TP53*      NM_000546      7157          ENST00000269305
  37   *XPA*      NM_000380      7507          ENST00000259463                                            
  38   *XPC*      NM_004628      7508          ENST00000285021                                            

Analyses of Gene Sequences, Mutations, and Evolutionary Rate
------------------------------------------------------------

Human and mouse reference sequences, and species gene numbers, were downloaded from NCBI Entrez Gene (<http://www.ncbi.nlm.nih.gov/Entrez/Gene>). Mutation data were downloaded from the Human Gene Mutation Database. K-estimator 6.1 (with window size of 33 codons and step size of 10 codons using Kimura 2-parameter \[2p\] method) ([@bib22]) and PAML 3.15 with yn00 model ([@bib147]) were used for evolutionary rate calculations. For analysis of gene evolutionary profiles, we downloaded coding sequences from Ensembl (<http://www.ensembl.org>). Kendall package from R-gui (<http://www.r-project.org>) was used for statistical analysis. Other analyses were done using MATLAB (7.6) Statistical Toolbox (5.1) (<http://www.mathworks.com>) for principal component analysis and nonparametric tests, and R-gui (2.60) for χ^2^ or Fisher\'s exact test.

Supergene Concatenation
-----------------------

Orthologous gene sequences of human, mouse, rat, chimpanzee, and rhesus monkey were aligned with amino acid sequences using ClustalW ([@bib137]), then reverted to codon sequences. In-house Perl scripts (available upon request) were developed for aligned codon concatenation. All the aligned CT and GK sequences were concatenated for supergene construction---23,100 codons for the GK supergene and 32,335 for the CT supergene. The supergene tree was constructed using a neighbor-joining method, with a modified Nei--Gojobori approach, as input in MEGA4 (codon substitution number Molecular Evolutionary Genetics Analysis software, version 4.0), producing 2 types of tree: synonymous and nonsynonymous substitution trees.

Coding Sequence Feature Analysis
--------------------------------

We used reference sequences downloaded from NCBI Entrez Gene. For multiple splicing forms, the longest coding sequence was used for analysis. Mono- and dinucleotide composition was assessed using in-house Perl scripts. Additional methodologic details are supplied in the supplements, text, and legends ([Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/msn126/DC1) online).

Results
=======

Phylogenetic Comparison of CT and GK Orthologs
----------------------------------------------

As an initial assessment, we quantified the numbers of human CT and GK orthologs among species of differing biological complexity. [Table 2](#tbl2){ref-type="table"} shows that orthologs of human CTs occur more often than those of GKs in unicellular (*P* = 0.047) than in multicellular organisms (*P* = 0.192)---suggesting that CTs are phylogenetically older, whereas GKs may be more essential to the evolution of multicellular organisms. Although this phylogenetic rise in GK ortholog frequency may reflect selection for increased developmental complexity as predicted by Cope\'s rule, it may also reflect the increasing importance of policing rogue elements (either intragenomic elements like meiotic drivers or intercellular outlaws like cancer cells) as multicellularity evolves and organismal cell number increases.

###### 

Phylogenetic and Gene Essentiality Profiles of Familial Cancer Syndrome Genes

  Parameters               CTs   GKs   *P* value
  ------------------------ ----- ----- -----------
  Yeast orthologs                      0.047
      Present              30    20    
      Absent               8     16    
  Worm orthologs                       0.192
      Present              30    33    
      Absent               8     3     
  Yeast essentiality                   0.63
      Deletion lethal      3     2     
      Deletion nonlethal   27    18    
  Worm essentiality                    0.003
      RNAi lethal          1     11    
      RNA nonlethal        29    22    
  Mouse essentiality                   \<0.00001
      Knockout lethal      4     28    
      Normal               21    8     
      Male infertility     13    0     

N[OTE]{.smallcaps}.---.For yeast phylogenetic analysis, CT analysis excludes the numerous Fanconi anemia gene orthologs in order to avoid data confounding. Gene knockout phenotypes were sourced using data mined from <http://www.informatics.jax.org/>. All *P* values were computed using Fisher\'s exact test (2 sided).

We next assessed differences in CT and GK gene essentiality ([@bib82]) based on deletion, RNAi, and gene-targeting data ([supplement 2](http://mbe.oxfordjournals.org/cgi/content/full/msn126/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/msn126/DC1) online). This analysis shows that germ line GK ortholog disruption is more often lethal than CT knockout in multicellular (worm RNAi data and mouse knockouts; *P* \< 0.00001, Fisher\'s exact test, 2 sided) but not in unicellular organisms (yeast deletions; *P* = 0.63; [table 2](#tbl2){ref-type="table"}). Hence, relative to GK function, germ line CT function appears selectively dispensable in multicellular organisms.

Analysis of mammalian gene-targeting phenotypes further reveals that, unlike GK knockouts, viable CT knockouts are associated with male sterility ([table 2](#tbl2){ref-type="table"}). We infer from this finding that CT dysfunction selectively permits (organism) viability at the expense of (genetic) fidelity, severe defects of which might be expected to cause sperm dysfunction or death. As discussed below, however, the possibility is raised that less profound (i.e., nondeletional or epimutational) germ line repair deficiencies could be associated with offspring fertility.

To assess further the impact of repair and apoptotic gene defects transmitted through the germ line, we compared CT and GK mutation frequencies in cancer families and somatic tumors. This shows that isolated germ line CT mutations are commoner than isolated GK mutations (*P* \< 0.00001; [table 3](#tbl3){ref-type="table"}), reinforcing the notion that CT/repair function is significantly more dispensable for survival than is GK/apoptosis function.

###### 

Mutational Analysis of Familial (germ line) and Sporadic (somatic) Human Tumor Mutations of CTs and GKs (i.e., relative frequencies of familial vs. sporadic human tumor mutations in the germ line and/or somatic lineages)

  Germ line versus somatic human tumor mutations   Germ line and somatic   Germ line only   *P* value
  ------------------------------------------------ ----------------------- ---------------- -----------
  CT (*n* = 38)                                    6                       32               \<0.00001
  GK (*n* = 36)                                    25                      11               

N[OTE]{.smallcaps}.---Mutation frequencies were determined by mining Cancer Gene Census and PubMed with *P* values computed using Fisher\'s exact test (2 sided).

Phylogenetic Analysis of Apoptosis versus Repair
------------------------------------------------

The foregoing data apply only to tumor suppressor genes. To determine whether these results can be generalized, we performed a cross-species quantitation of orthologs implicated in either apoptosis or repair ([supplement 1](http://mbe.oxfordjournals.org/cgi/content/full/msn126/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/msn126/DC1) online). Based on the assumptions that organism complexity is increasing from yeast to humans and that assignation of gene ontology includes some random effects, we performed Kendall rank test (R-gui Kendall package, [www.r-project.org](www.r-project.org)) for correlation analysis of DNA repair genes and apoptosis genes. As shown in [figure 1*A*](#fig1){ref-type="fig"}, phylogenetic differences in apoptosis gene numbers are significant (tau = 1, 2-sided *P* = 0.008535), whereas for DNA repair genes this is not the case (tau = 0.333, 2-sided *P* = 0.45237). Considered together with [table 2](#tbl2){ref-type="table"}, this difference confirms that increases in biological complexity depend more upon apoptotic than repair gene number.

![Evolutionary characteristics of human CTs and GKs. (*A*) Overall quantitation of apoptotic gene versus repair gene number in different phyla: human (*H. sapiens*), mouse (*Mus musculus*), fish (*D. rerio*), fly (*D. melanogaster*), worm (*C. elegans*), and yeast (*S. pombe*). Blue filled squares, DNA repair genes; red filled circles, apoptosis genes; black stars, total gene number of respective genome from Ensemble 49 ([www.ensembl.org](www.ensembl.org)). Data were mined as detailed in the Materials and Methods. (*B*) Relative divergence of CT and GK genes in mammals (human--mouse; divergence time approximately 85 MYA) and worms (*C. elegans*--*C. briggsae*; divergence time approximately 100 MYA) quantified using *Ka*/*Ks*. Blue squares, CT orthologs; red circles, GK orthologs. (*C*) Principal component analysis with parameters of *Ka*/*Ks* of CTs and GKs. We normalized the computed 10 pairwise divergence of human, chimpanzee, rhesus, monkey, mice, and rats using *Ka*/*Ks* analysis. 1st PC, first principal component (*x* axis); 3rd PC, third principal component (*y* axis).](molbiolevolmsn126f01_4c){#fig1}

Comparison of CT and GK Evolutionary Rates
------------------------------------------

We then used nonparametric 2-sample Kolmogorov--Smirnov goodness of fit hypothesis testing with kstest2 function (MATLAB, <http://www.mathworks.com>, statistical toolbox) for *Ka*/*Ks*---a positive correlate of positive selection---ortholog analysis. This confirmed that CTs evolve more rapidly than GKs in sexually reproducing (human vs. mouse, estimated divergence time 85 Myr; *P* = 0.000003) but not in self-fertilizing (2 worm species, estimated divergence time 100 Myr; *P* = 0.2582) multicellular organisms ([fig. 1*B*](#fig1){ref-type="fig"}; Kruskal--Wallis test, *P* \< 0.004); *Ks* was different in worms (*P* = 0.007) but not in mammals (*P* = 0.091). Consistent with our earlier finding of selective male sterility in CT knockouts, these data support the hypothesis that rapid CT evolution is related in some way to sexual reproduction. Principal component analysis based on evolutionary rate as well as variables such as GC content (see [fig. 5](#fig5){ref-type="fig"}) and gene length (see [supplement 3](http://mbe.oxfordjournals.org/cgi/content/full/msn126/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/msn126/DC1) online) provides further visual evidence that CTs and GKs are distinguishable based on genetic evolutionary parameters ([fig. 1*C*](#fig1){ref-type="fig"}).

We then used neighbor-joining supergene (gene concatenation) trees ([@bib152]) to characterize CT and GK branches under selection. This methodology, which has been reported to yield more accurate phylogenetic data than multigene approaches ([@bib46]), confirms that accelerated evolution of CTs compared with GKs is evident in human--macaca, human--mouse, and mouse--rat comparisons, though apparently not in human--chimpanzee comparisons ([fig. 2*A*](#fig2){ref-type="fig"}). This difference is further illustrated by a tree diagram showing the distinct divergence parameters of CTs and GKs ([fig. 2*B*](#fig2){ref-type="fig"}). It is noted that the ratio of missense to silent mutations (A/S) encoded by CT single-nucleotide polymorphisms (SNPs) is no higher than in GKs ([supplement 1](http://mbe.oxfordjournals.org/cgi/content/full/msn126/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/msn126/DC1) online) and that, compared with historical data ([@bib152]; [@bib38]), larger polymorphisms are present in both rare and common SNPs (*P* \< 0.001, Pearson\'s χ^2^). We have also noted that CTs evolve more rapidly than tissue-specific genes, whereas GKs evolve more slowly than housekeeping genes (*P* \< 0.001, Mann--Whitney *U* test; data not shown), emphasizing the wide class differences in evolutionary rates.

![Evolutionary rate comparison of CTs and GKs. (*A*) Distribution of *Ka*/*Ks* in pairwise comparisons between CTs and GKs within 4 lineages including human--chimpanzee (top left), human--macaca (top right), human--mouse (bottom left), and human--rat (bottom right). Bin size 0.05 was used for distribution computation. For this analysis---which compares the different evolutionary rates of human CTs and GKs using a variety of species comparators, as distinct from comparing gene evolutionary rates in multiple species---*P* values were calculated by ranked 2-sample Mann--Whitney *U* test using MATLAB Statistical toolbox function rank sum. (*B*) Lineage-specific comparison of evolutionary rate of CTs and GKs using supergene concatenation. Blue bars, CTs; red bars, GKs.](molbiolevolmsn126f02_4c){#fig2}

To explore possible differences of divergence between CTs and GKs, we used a sliding window analysis of concatenated CT (38 genes, 41,169 codons) and GK (36 genes, 25,968 codons) supergenes. A window size of 33 codons and step size of 10 codons was used in conjunction with K-estimator (calculation of the number of nucleotide substitutions per site and the confidence intervals) 6.1, Kimura 2p model. As shown in [figure 3*A*](#fig3){ref-type="fig"}, the Ka/Ks (red), but neither Ka nor Ks (green and blue, respectively), is overrepresented in CTs compared with GKs. We further tested the distribution of these 3 parameters by using the nonparametric 2-sample Kolmogorov--Smirnov test. [Figure 3*B*](#fig3){ref-type="fig"} confirms that only *Ka*/*Ks* is significant (*P* = 0.0000079) but neither Ka nor Ks, which correlate with deleterious mutation and neutral mutation rate, respectively (for further details, see supplement \[[Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/msn126/DC1) online\] and [fig. 3](#fig3){ref-type="fig"}).

![Sliding window analysis of human--mouse CT and GK divergence. (*A*) Evolutionary rates of CTs (top) and GKs (bottom) using human--mouse alignments (window size 33 codons, step size 10 codons). Red line, *Ka*/*Ks*; blue line, *Ks*; green line, *Ka*. Most regions with *Ka*/*Ks* \>1.5, with *P* value \<0.05 (bootstrap threshold computed with K-estimator 6.1). (*B*) Distribution of Ka, Ks, Ka/Ks in CTs and GKs using bin size 0.05 and nonparametric Kolmogorov--Smirnov test, revealing a significant difference of Ka/Ks (*P* = 0.0000079), thus confirming more rapid evolution of CTs than GKs.](molbiolevolmsn126f03_4c){#fig3}

To check whether human--chimpanzee divergences of CTs and GKs are in fact similar, as suggested by the findings in [figure 2](#fig2){ref-type="fig"}, we used the [@bib92] test for evolutionary rate analysis. Data were mined as described ([@bib13]) using a Poisson random field model---a variant of the McDonald--Kreitman test---for divergence versus diversity comparison. Data were obtained from Celera Genomics, which applied exon-specific polymerase chain reaction amplification to 20,362 loci in 39 humans and 1 male chimpanzee. We note, however, that the following genes were not found in this data set: 9 CTs (*BRCA2*, *BRIP1*, *FANCD2*, *FANCM*, *MLH1*, *MLH3*, *NBN*, *PMS2*, and *RECQL4*) and 10 GKs (*CDC73*, *EXT1*, *NF1*, *PTCH*, *SBDS*, *SDHD*, *TSHR*, *WT1*, *CHEK2*, and *FH*). The following parameters were used: synonymous divergence, synonymous polymorphism, nonsynonymous divergence (DN), nonsynonymous polymorphism (PN), and γ (Poisson random field model parameters). All mined data are supplied (supplement \[[Supplementary Material](http://mbe.oxfordjournals.org/cgi/content/full/msn126/DC1) online\] and [fig. 4](#fig4){ref-type="fig"}). In contrast to [figure 2](#fig2){ref-type="fig"}, these results---which show a higher frequency of GKs lacking both PN and DN sites relative to CTs (Pearson\'s χ^2^, *P* = 0.0044)---confirm that the rapid evolution of CTs relative to GKs persisted during the human--chimpanzee divergence approximately 10 MYA ([fig. 4*A*--*D*](#fig4){ref-type="fig"}). Hence, having shown that CTs evolved faster than GKs both during primate--rodent ([figs. 1--3](#fig1 fig2 fig3){ref-type="fig"}) and human--chimpanzee divergence ([fig. 4](#fig4){ref-type="fig"}), we conclude that the rapid evolution of CTs is likely independent of timescale.

![McDonald--Kreitman testing of CT evolutionary rate relative to GKs during human--chimpanzee divergence. (*A*) Distributions of synonymous divergence (DS), synonymous polymorphism (PS), nonsynonymous divergence (DN), and nonsynonymous polymorphism (PN) of CTs and GKs using bin size 1 and nonparametric tests (median of 2 unpaired samples, using the MATLAB 7.6 statistical toolbox rank-sum function). This shows that DN is the most significant parameter (*P* = 0.00016), followed by PN (*P* = 0.004), with DS and PS not significant, thus confirming rapid CT evolution. (*B*) R-gui function χ^2^ test function in terms of the summarized codon changes of CTs and GKs. This also shows that the evolutionary rates of CTs and GKs are different (*P* = 0.0000037). (*C*) Poisson random field parametric test. The selection parameters are illustrated using a 95% confidence interval and show no significant difference (*P* = 0.1913, by nonparametric test of equal distribution of 2 samples using function kstest2), presumably reflecting numerous nonchange genes in terms of the parameters. (*D*) Parametric retesting of CT and GKs in terms of DS, PS, DN, and PN, confirming that CTs evolved more rapidly than GKs during human--chimpanzee divergence.](molbiolevolmsn126f04_4c){#fig4}

Sequence-Based Evidence for Evolutionary CT Gene Methylation
------------------------------------------------------------

Our previous studies implicated nonrandom CG → TA transitional mutations (CpG decay) as a correlate of adaptive evolution in less transcribed ([@bib134]) and/or less essential coding sequences ([@bib33]); conversely, we have implicated CpG conservation as a correlate of negative selection in more transcribed ([@bib135]) and/or more essential sequences ([@bib83]). These results suggested an evolutionary paradigm in which concomitant promoter and coding sequence methylation accelerate (epi)mutational functional loss of nonessential coding sequences. To test whether any such methylation-dependent signatures distinguish CTs and GKs, we computed the sequence component of the relevant transcribed coding strand and applied a nonparametric 2-sample Kolmogorov--Smirnov goodness of fit hypothesis test with kstest2 function of MATLAB (<http://www.mathworks.com>) statistical tool box for all parameters compared. Meaningful CT and GK gene expression data were unable to be derived from GNF Expression Atlas 2 based on U133A and GNF1H Chips, perhaps reflecting parametric uncertainty ([@bib131]). However, for gene expression-related sequence features relating to CpG mutation and asymmetric transcription-related repair ([@bib135]), we compared GC content ((G + C)/(G + C + A + T), *P* = 0.0106), TA skew ((T − A)/(T + A), *P* = 0.5242), GC skew ((G − C)/(G + C), *P* = 0.0028), and B factor ((G + T − A − C)/(A + T + G + C), *P* = 0.0860) ([@bib85]) ([fig. 5*A*](#fig5){ref-type="fig"}). These differences suggest greater methylation-dependent mutation of CTs relative to GKs during recent human evolution. We then compared the methylation-related sequence features of CT/GK transcribed strands, revealing differences in CpG content (CpG count/total dinucleotide count, *P* = 0.0011), CpA content (CpA count/total dinucleotide count, *P* = 0.2555), TpG content (TpG count/total dinucleotide count, *P* = 0.0174), and DNA methylation-related dinucleotide asymmetry (TpG × CpA)/(CpG × CpG), *P* = 0.00105) ([fig. 5*B*](#fig5){ref-type="fig"}). These results indicate less transcription-related repair of methylated CTs relative to GKs in germ line--coding sequences. Considered together with the gene essentiality differences presented in [table 2](#tbl2){ref-type="table"}, the rapid evolution of CTs relative to GKs suggests an epimutational mechanism for CT functional inhibition that escapes purification while accelerating mutation.

![Box plot illustration of CT- and GK-coding sequence features relating to DNA methylation and gene expression. The boxes feature lines at the lower quartile, median, and upper quartile values. The whiskers are lines extending from each end of the boxes to show the extent of the data; outliers are values beyond the ends of the whiskers. (*A*) Comparison of GC content and dinucleotide skew in CTs and GKs. (*B*) Frequency of methylation-related dinucleotides and asymmetry in CTs versus GKs. Outliers are denoted by plus signs.](molbiolevolmsn126f05_4c){#fig5}

![Model of changing human male CT and GK function from germ line to somatic contexts. The *x* axis is divided into the following time frames: *T*1, prezygotic spermatogonia and spermatocytes; *T*2, postzygotic embryonic development; *T*3, prereproductive infancy and childhood; *T*4, reproductive adult life; and *T*5, postreproductive senescence. The *y* axis models the relative extent of either GK functionality (PCD) or CT dysfunctionality (PGI) during these time frames. Damage/stress-inducible prezygotic promoter (CpG island) methylation of spermatogonial/spermatocyte CTs and GKs, respectively, increases PGI while reducing PCD---thus maximizing genetic variability in response to changing environmental selection pressures. Postfertilization male germ line gene demethylation has the opposite effect, causing a sustained decline in PGI and a rise in PCD. During postreproductive adult life, an age-dependent (as well as damage-inducible) methylation clock induces somatic CT/GK gene inactivation, leading in turn to a senescent rise in PGI and decline of PCD that predisposes to sporadic tumor outgrowth.](molbiolevolmsn126f06_4c){#fig6}

Discussion
==========

The central finding of this study is that CTs are evolving more rapidly than GKs and that this process---which appears likely to be mediated by methylation-dependent mutation---is confined to higher sexually reproducing species. These CT--GK distinctions are consistent with earlier work showing that apoptosis-regulatory genes are essential for development of higher organisms ([@bib5]), whereas germ line mutation of DNA repair genes drives species evolution ([@bib38]). However, because loss of DNA repair capacity also contributes to cancer development ([@bib20]; [@bib12]), it is also reasonable to expect tumor suppressor genes in general to be under strong purifying selection ([@bib136]). Here, we propose that this apparent discrepancy arises from a complex mix of dualistic variables: 1) the bifunctional evolutionary role of repair genes in either conserving genetic information or permitting genetic variation, depending on selection pressure; 2) the bifunctional ability of sexual reproduction either to promote (prezygotically) variation through repair inhibition and intra- or intermale sperm competition or to conserve (postzygotically) genetic fidelity through repair activation, apoptosis, and miscarriage; and 3) the bifunctional role of CpG dinucleotides and promoter CpG islands in either enhancing transcription and repair (when demethylated) or in repressing transcription and predisposing to mutation (when methylated).

Epigenetic reprogramming occurs not only in the early embryo, where somatic patterns of gene expression are set, but also during germ cell development ([@bib97])---which changes can be heritable for at least 2 generations ([@bib4]). The methylation dynamics of sperm/testis DNA are unique ([@bib105]); unlike oocyte DNA, prezygotic protamine-compacted male germ cell DNA tends to be methylated in nonpromoter regions ([@bib106]) that undergo rapid demethylation following fertilization ([@bib53]). Such sex-specific DNA methylation appears necessary but not sufficient ([@bib32]) to explain the higher mutation rate of mammalian male germ cells ([@bib2]; [@bib64]; [@bib146]; [@bib86])---suggesting in turn that exposures of the (external) testes to heat ([@bib103]), DNA damage ([@bib7]), or other insults ([@bib55]) could well play an evolutionarily programmed epimutagenic role, consistent with the postnatal timing of male germ cell promoter methylation ([@bib29]). Notably, this hypothesis differs from the standard view of male-driven evolution reflecting a simple excess of male germ cell divisions, giving rise in turn to more replicative mutations ([@bib30]).

In earlier work, we showed that rarely transcribed genes with promoter CpG islands are hot spots for adaptive evolution ([@bib134]), raising the possibility that promoter methylation of sperm target gene classes such as CTs could be a mechanistic "missing link" between environmental selection for specific transcriptomes ([@bib131]) and/or coding sequence CpG mutations that permit transgenerational propagation of genetic instability ([@bib145]; [@bib96]). Consistent with this, CTs more often contain promoter CpG islands than do GKs (Zhao Y, unpublished data): classic GKs such as *TP53* do not contain promoter CpG islands, whereas canonical CTs such as *MLH1* and *BRCA1* do. Instructively, the latter gene is mutated and not methylated in familial cancer syndromes ([@bib17]), yet is methylated and not mutated in chemotherapy-induced second malignancies ([@bib123]); similar exclusivity between repair gene methylation events and oncogenic indels or point mutations in repair-deficient tumors ([@bib36]; [@bib138]) suggests the fluidity of such epimutations. Although in this model extrinsic damage is the major regulator of prezygotic male germ cell CT methylation---as well as being both a cause and effect of progressive suppressor gene repression in precancerous adult somatic tissues ([@bib101])---age may be as important as damage in the latter process ([@bib71]), with parental (especially paternal) age playing a synergistic role in the former ([@bib107]).

We define this model of a "methylation clock" regulating the epigenetic inactivation of CT/repair genes in the male germ line and adult somatic tissues---commensurate with extrinsic damage/stress or intrinsic ageing/senescence---as PGI; just as programmed cell death (PCD) is the mechanism of negative selection, so is PGI proposed to be the mechanism of positive selection ([fig. 6](#fig6){ref-type="fig"}). We suggest that PGI intensifies genetic divergence during sexual reproduction at the level of sperm--egg fusion, in contrast to PCD which eliminates both oocyte ([@bib132]) and sperm DNA defects after syngamy ([@bib37]). This sequence (sperm → ovum, zygote → embryo) of positive followed by negative selection fits with the notion of sexual conflict ([@bib111]), which should enhance biological system robustness and evolvability ([@bib76]). We also note that heritable, though not necessarily familial, predisposition to carcinogenesis could also be propagated transgenerationally by PGI ([@bib35]).

What evidence do we have for PGI operating through the male germ line? The original hypothesis arose from prior knowledge, namely, 1) evidence for male-driven evolution from other groups ([@bib2]; [@bib64]; [@bib146]; [@bib86]); 2) evidence for repair genes being speciation genes, implying a permissive role in rapid evolution ([@bib119]; [@bib20]; [@bib129]); and 3) the external anatomic location of the testis, making male germ cells uniquely vulnerable to mutagenic, yet potentially reparable, environmental damage ([@bib120]; [@bib63]; [@bib39]). Against this background, we needed to integrate the following new data: 1) CT/repair genes are evolving with unexpected rapidity; 2) CT knockouts are relatively dispensable for survival, resulting only in reduced male fertility; and 3) abnormally low CT/repair gene expression is characteristic of teratozoospermia (Zhao Y, unpublished data), a condition of abnormal sperm morphology that does not significantly reduce in vitro fertilization success rates ([@bib69]). These considerations invited the hypothesis: could the rapid evolution of CT/repair genes reflect selection for a permissive (i.e., causal loss-of-function) role in male-driven evolution? This latter possibility is supported by the finding that heterozygous males and homozygous females can remain fertile when homozygous male repair gene knockouts are sterile (Roest 1996) and that even minimal repair transgene expression suffices to rescue fertility in repair-knockout males (Hsia 2003). Moreover, homozygous repair-deficient males may survive---albeit at the cost of tumor susceptibility---in genetic backgrounds where homozygous females die ([@bib24]). This striking gender-specific difference strongly suggests a male-specific significance for accelerated CT evolution, which involves interaction of ambient damage with selection for subtle (e.g., epimutational) male germ cell repair defects.

Our gene targeting and familial cancer data confirm that germ line CT defects are less lethal than GK defects ([tables 2](#tbl2){ref-type="table"} and [3](#tbl3){ref-type="table"}). The effects of repair gene targeting depend critically on the extent of functional inhibition and the presence or otherwise of associated mutations; in general, mild (e.g., haploinsufficient) CT/repair defects tend to increase mutation while decreasing apoptosis ([@bib43]; [@bib127]) and may even enhance fitness and lifespan ([@bib125]), whereas severe repair defects tend to cause increased apoptosis and premature lethality ([@bib58]). Hence, because low-level sperm DNA damage can be repaired after fertilization of repair-proficient oocytes ([@bib93]; [@bib87]; [@bib40])---particularly in the setting of prior DNA damage "conditioning" of such oocytes ([@bib1])---mild nondeletional prezygotic male germ line repair defects could plausibly enhance sperm divergence with minimal fertility compromise, thereby safeguarding species' evolvability while offsetting transgenerational risks of paternally transmitted birth defects ([@bib88]) or cancer ([@bib151]; [@bib149]). This conclusion is further supported by the finding that chronic exposure of spermatogonia to low-dose damage greatly reduces genetic damage induced by an acute second hit ([@bib14]; [@bib78]). Our findings therefore suggest the evolution of an environmentally interactive genetic program for promoting divergence in the germ line. We note that the related age-dependent predisposition to cancer is not wholly disadvantageous to the species as such mortality may promote redistribution of environmental resources to younger and more fertile individuals.

As an extension of the "immortal strand" hypothesis of stem cell fidelity ([@bib15]), our findings raise the notion that the transcribed (well repaired, CpG-demethylated) DNA strand represents the "immovable object" of negative selection, whereas the untranscribed (poorly repaired, CpG-methylated) strand provides the "irresistible force" of positive selection. Furthermore, consistent with the notion that sexual conflict selects for distinct gender phenotypes ([@bib62]), the evolutionary paradigm presented here implies that the usual targets of positive selection---choice and specialization ([@bib8]; [@bib54]), discrimination and success ([@bib133]), and beauty ([@bib98])---are intrinsically male (sperm/PGI dependent) in origin, whereas the targets of negative selection (normality, utility, longevity, and fidelity) are genetically female or oocyte/PCD dependent. Both positively and negatively selected traits are vital for fitness in sexually reproducing species: for example, the reproductive success of butterflies, birds, and peacocks depends on highly variegated yet symmetric surface patterns ([@bib51]) that predict a low underlying frequency of deleterious functional mutations ([@bib98]). In our model, PGI is driven by sexual selection pressure on the male germ line to optimize as opposed to normalize whatever phenotypes can be optimized---such as sperm velocity ([@bib47]) or ion channel function regulating motility ([@bib116])---while also enhancing variation in species-discriminatory phenotypes such as egg-binding proteins ([@bib94]). Hence, the basis for sexual conflict in our model is that "average" can never be "best" and that "health" may not guarantee "popularity" ([@bib150])---whether with respect to beauty ([@bib26]) or to sperm competition ([@bib99])---thus helping to explain the paradox that mutation rates tend to be reduced by natural selection yet increased by sexual selection ([@bib94]).

In conclusion, we have shown that CTs are less essential for germ line viability and hence more rapidly evolving than GKs. The resulting model of PGI implicates sexual reproduction as an evolutionary masterstroke: uniquely, sex plays off prezygotic positive selection (in which epimutational divergence is accelerated by environmental stress and damage, and efficiently selected and fixed by intra- and/or intermale sperm competition) against the evolutionary safety valves of postzygotic repair and negative selection ([@bib93]). Via this mechanism, we propose that environmental stressors succeed in the otherwise oxymoronic task of "selecting for divergence" via epigenetic inhibition of DNA repair, thus helping to settle the "4-billion-year struggle of selfish genes to balance the need for variation with the equally important goal of conserving success" ([@bib51]). Moreover, if tumors do indeed arise in part as a side effect of PGI, cancer susceptibility may be most accurately viewed as the tumor-permissive "price" paid by multicellular organisms for genetic plasticity, with the species reaping the ultimate evolutionary "reward" of a delayed time to extinction.
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